Multiplicom Receives $250K Grant to Develop Genetic Fetal Aneuploidy Test | GenomeWeb

NEW YORK (GenomeWeb News) – Belgian molecular diagnostics firm Multiplicom today said it has been awarded €200,000 ($250,000) to develop a blood-based non-invasive fetal aneuploidy test.

The grant from the Flemish agency for Innovation by Science and Technology will be used by Multiplicom to develop the test based on its Multiplex Amplification of Specific Targets for Resequencing workflow. The PCR-based test detects copy number variations in chromosomes 21, 18, 13, X and Y in fetal DNA isolated from the mother's blood.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.